Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-21-005587
Date:2021-11-26
Issuer: ALLIED HEALTHCARE PRODUCTS INC (AHPI)
Original Submission Date:

Reporting Person:

WEIL JOHN D
4625 LINDELL BLVD., #335
ST. LOUIS, MO 63108

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-11-26 S 69,249 d $8.44 25,178 indirect
COMMON STOCK 2021-11-26 S 59,101 d $8.47 0 indirect
COMMON STOCK 2021-11-26 S 7,514 d $8.06 0 indirect
COMMON STOCK 2021-11-26 0 $0.00 53,810 indirect
COMMON STOCK 2021-11-26 0 $0.00 90,513 direct
COMMON STOCK 2021-11-26 0 $0.00 2,500 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION TO PURCHASE COMMON STOCK 5.09 2021-11-11 deemed execution date A 750 (a) 2022-11-11 2031-11-11 common stock 750 $5.09 750 direct
OPTION TO PURCHASE COMMON STOCK 5.18 deemed execution date 0 ( ) 2013-11-08 2022-11-08 common stock 750 $5.18 750 direct
OPTION TO PURCHASE COMMON STOCK 4.62 deemed execution date 0 ( ) 2014-11-14 2023-11-14 common stock 750 $4.62 750 direct
OPTION TO PURCHASE COMMON STOCK 3.16 deemed execution date 0 ( ) 2015-11-13 2024-11-13 common stock 750 $3.16 750 direct
OPTION TO PURCHASE COMMON STOCK 2.34 deemed execution date 0 ( ) 2016-11-12 2025-11-12 common stock 750 $2.34 750 direct
OPTION TO PURCHASE COMMON STOCK 2.26 deemed execution date 0 ( ) 2017-11-10 2026-11-10 common stock 750 $2.26 750 direct
OPTION TO PURCHASE COMMON STOCK 2.22 deemed execution date 0 ( ) 2018-11-09 2027-11-09 common stock 750 $2.22 750 direct
OPTION TO PURCHASE COMMON STOCK 2.13 deemed execution date 0 ( ) 2019-11-08 2028-11-08 common stock 750 $2.13 750 direct
OPTION TO PURCHASE COMMON STOCK 1.17 deemed execution date 0 ( ) 2020-11-07 2029-11-07 common stock 750 $1.17 750 direct
OPTION TO PURCHASE COMMON STOCK 7.86 deemed execution date 0 ( ) 2021-11-12 2030-11-12 common stock 750 $7.86 750 direct
Footnotes
IDfootnote
f1 the reported price is a weighted average price. these shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f2 the reporting person disclaims any economic benefit in such shares.
f3 owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
f4 owned by a corporation controlled by the reporting person.
f5 owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. the decrease of 6,710 reported shares between the amount reported in this filing and the amount reported in the most recent previous filing is due to omission of a trust for which the reporting person no longer serves as trustee and with respect to which the reporting person no longer has any pecuniary interest.
f6 issued pursuant to the company's 2013 director's stock option plan.

Elevate your investments